Back to Authors

Yu, Stephanie

A5112295617 | I4210125099

Mayo Clinic

Mayo Clinic in Arizona

Citations 1

Metabolic inflammation and cancer risk: A potential target with GLP‐1 agonist or bariatric surgery?

Cancer | October 15, 2025 | Volume: 131 | Issue: 20 | Pages: No page available

10.1002/cncr.70124 | PMID 41091624

The authors explore the association of remnant cholesterol and CRP with the longitudinal development of cancer in a prospective cohort study and if there is an opportunity to modulate risk with bariatric surgery or GLP‐1 agonist.